Delhi HC Clears Zydus’ Cancer Drug ZRC-3276 Despite BMS Patent Claim
New Delhi: In a judgment of far-reaching significance for India's pharmaceutical and patent jurisprudence, the Delhi High Court has allowed Zydus Lifesciences to manufacture and sell its cancer drug ZRC-3276,…
